4/A
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001209191-23-021542
Chief Financial Officer acquired 51,346 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Colgan Erin Chief Financial Officer | 2023-02-15 | Grant or award | +30,046 | 57,732 | D | ||
| Colgan Erin Chief Financial Officer | 2023-02-15 | Grant or award | +21,300 | 79,032 | D | ||
| Derivatives | |||||||
| Colgan Erin Chief Financial Officer | 2023-02-15 | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | D | ||
Loading xslF345X04/doc4a.xml…